Literature DB >> 8500147

Validation of diagnostic criteria for migraine in the Zürich longitudinal cohort study.

K R Merikangas1, A E Whitaker, J Angst.   

Abstract

This paper reports the results of a systematic assessment of the validity of the specific diagnostic criteria for migraine without aura, as defined by the International Headache Society (IHS), in a longitudinal epidemiologic sample of young adults who were selected from the general population of Zürich, Switzerland. Systematic modification of each of the IHS criteria for migraine without aura yielded one-year weighted prevalence rates ranging from 24% for the unmodified IHS criteria to 9% for the most restrictive definition of migraine. The major implications of the findings for the IHS criteria are: (a) they provide adequate coverage to classify the majority of subjects with headache in the general population; (b) there is little overlap between migraine and tension-type headache, suggesting that the criteria define moderately independent subgroups; (c) the criteria for migraine without aura appear to be too unrestrictive for application in the community, particularly among young adults at the peak period of incidence of migraine; (d) the criteria for "aura" need more precise operationalization; and (e) models of validation of the diagnostic criteria suggest that Criterion D of the IHS criteria for migraine without aura should be modified to require both gastrointestinal symptoms and photophobia and phonophobia.

Entities:  

Mesh:

Year:  1993        PMID: 8500147     DOI: 10.1177/0333102493013S1210

Source DB:  PubMed          Journal:  Cephalalgia        ISSN: 0333-1024            Impact factor:   6.292


  5 in total

1.  Sensitivity and specificity of the new international diagnostic criteria for migraine with aura.

Authors:  M K Eriksen; L L Thomsen; J Olesen
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-02       Impact factor: 10.154

2.  [Not Available].

Authors:  H Göbel
Journal:  Schmerz       Date:  1995-07       Impact factor: 1.107

3.  Genomewide significant linkage to migrainous headache on chromosome 5q21.

Authors:  Dale R Nyholt; Katherine I Morley; Manuel A R Ferreira; Sarah E Medland; Dorret I Boomsma; Andrew C Heath; Kathleen R Merikangas; Grant W Montgomery; Nicholas G Martin
Journal:  Am J Hum Genet       Date:  2005-07-28       Impact factor: 11.025

4.  The Zurich Study: XXIII. Epidemiology of headache syndromes in the Zurich cohort study of young adults.

Authors:  K R Merikangas; A E Whitaker; H Isler; J Angst
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1994       Impact factor: 5.270

5.  [Prevalence of headache syndromes in Germany.].

Authors:  H Göbel; M Petersen-Braun; D Soyka
Journal:  Schmerz       Date:  1993-12       Impact factor: 1.107

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.